Alginate-regulating genes are identified in the clinical cystic fibrosis isolate of Pseudomonas aeruginosa PA2192
Brett ColbertiD, Hansi Kumari, Ana Piñon, Lior Frey, Sundar Pandey, Kalai Mathee
Abstract
Cystic fibrosis (CF) is a genetic disorder that leads to a buildup of mucus in the lungs ideal for bacterial colonization. When Pseudomonas aeruginosa enters the CF lung, it undergoes a conversion from nonmucoid to mucoid; colonization by a mucoid strain of P. aeruginosa greatly increases mortality. The mucoid phenotype is due to the production of alginate. The regulator of alginate production is the AlgT/U sigma factor. The observed phenotypic conversion is due to a mutation in the mucA gene coding for an anti-sigma factor, MucA, which sequesters AlgT/U. This mucoid phenotype is unstable when the strains are removed from the lung as they acquire second-site mutations. This in vitro reversion phenomenon is utilized to identify novel genes regulating alginate production. Previously, second-site mutations were mapped to algT/U, algO, and mucP, demonstrating their role in alginate regulation. Most of these studies were performed using a non-CF isolate. It was hypothesized that second site mutations in a clinical strain would be mapped to the same genes. In this study, a clinical, hyper-mucoid P. aeruginosa strain PA2192 was used to study the reversion phenomenon. This study found that PA2192 has a novel mucA mutation which was named them mucA180 allele. Twelve colonies were sub-cultured for two weeks without aeration at room temperature in order to obtain nonmucoid suppressors of alginate production (sap). Only 41 sap mutants were stable for more than 48 hours -- a reversion frequency of 3.9% as compared to ~90% in laboratory strains showing that PA2192 has a stable mucoid phenotype. This phenotype was restored in 28 of the 41 sap mutants when complemented with plasmids harboring algT/U. Four of the sap mutants are complemented by algO. Sequence analyses of the algT/U mutants have found no mutations in the coding region or promoter leading to the hypothesis that there is another, as yet unidentified mechanism of alginate regulation in this clinical strain.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The anti-sigma factor MucA is required for viability in Pseudomonas aeruginosa
M. C. Schofield, D. Rodriguez, … B. S. Tseng·bioRxiv·Aug 17, 2020
- Overproduction of the AlgT sigma factor is lethal to mucoid Pseudomonas aeruginosa
A. R. Cross, V. Raghuram, … J. B. Goldberg·bioRxiv·Jun 5, 2020
- Identification of Pseudomonas aeruginosa genetic determinants that connect redox metabolism to alginate biosynthesis
Soo-Kyoung Kim, Nishad Thamban Chandrika, … Vincent T. Lee·bioRxiv·Feb 6, 2026
- In vivo and in vitro analysis of the role of the Prc protease in inducing mucoidy in Pseudomonas aeruginosa
Alexis G. Sommerfield, Michelle Wang, … Andrew J. Darwin·Journal of BacteriologyPeer-reviewed·Sep 17, 2024
- Exogenous alginate protects Staphylococcus aureus from killing by Pseudomonas aeruginosa
C. E. Price, D. G. Brown, … G. O'Toole·Journal of BacteriologyPeer-reviewed·Mar 26, 2020
- Canonical pathoadaptive cystic fibrosis genes in Pseudomonas aeruginosa are not CF-specific
Iris Irby, Elijah C. Mehlferber, Sam P. Brown·bioRxiv·Aug 19, 2026